Unity Biotechnology
AUDIT: Unity Biotechnology: Auditing Metabolic Bankruptcy and Senolytic Insolvency
Audit the $700M collapse of Unity Biotech. Explore the clinical failure of senolytics, SASP, and how metabolic bankruptcy led to DGCL 275 dissolution.